Question 1

Should I use a disorder-specific CBT manual or a transdiagnostic protocol for my comorbid patient?

Accepted Answer

Barlow's Unified Protocol (UP) produces outcomes statistically equivalent to disorder-specific protocols (d=-0.93 vs -1.08, 223 adults; Barlow et al., 2017, JAMA Psychiatry; PMID 28768327), with equivalence maintained at 36 months (Bullis et al., 2023; PMID 40655560). A 2024 Nature Human Behaviour meta-analysis (53 studies, 6,705 participants; Schaeuffele et al., 2024; PMID 38228727) confirms parity for primary anxiety (g=0.77) with moderately superior effects on comorbid depression. UP completion rate 87.5% vs SDPs 69.2% (OR=3.11). Favor transdiagnostic when: multiple comorbid anxiety disorders, practice cannot form disorder-specific groups (Norton TCBT solves this). Favor disorder-specific when: single diagnosis with a superior protocol (Clark & Wells for SAD SMD=-1.56, OST for specific phobias, IBT-SM for selective mutism, applied tension for BII phobia).

Question 2

How do the Unified Protocol outcomes compare to disorder-specific protocols?

Accepted Answer

Barlow's Unified Protocol (UP) produces outcomes statistically equivalent to disorder-specific protocols (d=-0.93 vs -1.08, 223 adults; Barlow et al., 2017, JAMA Psychiatry; PMID 28768327), with equivalence maintained at 36 months (Bullis et al., 2023; PMID 40655560). A 2024 Nature Human Behaviour meta-analysis (53 studies, 6,705 participants; Schaeuffele et al., 2024; PMID 38228727) confirms parity for primary anxiety (g=0.77) with moderately superior effects on comorbid depression. UP completion rate 87.5% vs SDPs 69.2% (OR=3.11). Favor transdiagnostic when: multiple comorbid anxiety disorders, practice cannot form disorder-specific groups (Norton TCBT solves this). Favor disorder-specific when: single diagnosis with a superior protocol (Clark & Wells for SAD SMD=-1.56, OST for specific phobias, IBT-SM for selective mutism, applied tension for BII phobia).

Question 3

If 50-80% of anxious patients have comorbidities, when does disorder-specific still make sense?

Accepted Answer

Barlow's Unified Protocol (UP) produces outcomes statistically equivalent to disorder-specific protocols (d=-0.93 vs -1.08, 223 adults; Barlow et al., 2017, JAMA Psychiatry; PMID 28768327), with equivalence maintained at 36 months (Bullis et al., 2023; PMID 40655560). A 2024 Nature Human Behaviour meta-analysis (53 studies, 6,705 participants; Schaeuffele et al., 2024; PMID 38228727) confirms parity for primary anxiety (g=0.77) with moderately superior effects on comorbid depression. UP completion rate 87.5% vs SDPs 69.2% (OR=3.11). Favor transdiagnostic when: multiple comorbid anxiety disorders, practice cannot form disorder-specific groups (Norton TCBT solves this). Favor disorder-specific when: single diagnosis with a superior protocol (Clark & Wells for SAD SMD=-1.56, OST for specific phobias, IBT-SM for selective mutism, applied tension for BII phobia).

Question 4

What's the practical decision rule for choosing between approaches?

Accepted Answer

Barlow's Unified Protocol (UP) produces outcomes statistically equivalent to disorder-specific protocols (d=-0.93 vs -1.08, 223 adults; Barlow et al., 2017, JAMA Psychiatry; PMID 28768327), with equivalence maintained at 36 months (Bullis et al., 2023; PMID 40655560). A 2024 Nature Human Behaviour meta-analysis (53 studies, 6,705 participants; Schaeuffele et al., 2024; PMID 38228727) confirms parity for primary anxiety (g=0.77) with moderately superior effects on comorbid depression. UP completion rate 87.5% vs SDPs 69.2% (OR=3.11). Favor transdiagnostic when: multiple comorbid anxiety disorders, practice cannot form disorder-specific groups (Norton TCBT solves this). Favor disorder-specific when: single diagnosis with a superior protocol (Clark & Wells for SAD SMD=-1.56, OST for specific phobias, IBT-SM for selective mutism, applied tension for BII phobia).

PsychHQ

Transdiagnostic vs. Disorder-Specific CBT: When Does the Unified Protocol Win?